文献速递肾移植

IgE介导免疫反应与抗体介导排斥反应的关系

IgE-Mediated Immune Response and Antibody-Mediated Rejection.
PubMed 文献 · Clin J Am Soc Nephrol · 2020-09-09

本研究为横断面研究,纳入56例活检证实的抗体介导排斥反应受者、80例移植功能正常对照、16例间质纤维化/肾小管萎缩及6例SLE患者,评估移植肾IgE沉积、肥大细胞与活化嗜碱性粒细胞标志物及血清MxA、抗HLA IgE。结果发现抗体介导排斥反应组肾小管与肾小球IgE沉积显著高于间质纤维化/肾小管萎缩组和对照组,且存在循环抗HLA IgE、肥大细胞与活化嗜碱性粒细胞,血清MxA升高并与IgE沉积程度相关。提示IgE沉积及后续嗜碱性粒细胞和肥大细胞募集可能参与抗体介导排斥反应。

要点

  • 抗体介导排斥反应组肾小管与肾小球IgE沉积显著高于间质纤维化/肾小管萎缩组和对照组。
  • 抗体介导排斥反应患者存在循环抗HLA IgE抗体,但平均荧光强度低。
  • 抗体介导排斥反应组血清MxA显著高于对照组,且与IgE沉积程度相关。

核心结论

  • IgE沉积及后续嗜碱性粒细胞和肥大细胞在移植肾内募集可能参与抗体介导排斥反应。

研究设计与样本

  • 横断面研究,纳入56例活检证实的抗体介导排斥反应受者、80例移植功能正常对照、16例间质纤维化/肾小管萎缩及6例SLE患者。

主要发现

  • 抗体介导排斥反应组肾小管与肾小球IgE沉积为1766±79像素,SLE组为1495±43像素,间质纤维化/肾小管萎缩组为582±122像素,对照组为253±50像素。
  • 抗体介导排斥反应患者存在循环抗HLA IgE抗体,但平均荧光强度低;对照组和间质纤维化/肾小管萎缩组未提及存在。
  • 免疫荧光显示抗体介导排斥反应组存在肥大细胞和活化嗜碱性粒细胞,而对照组和间质纤维化/肾小管萎缩组未提及。
  • 抗体介导排斥反应组循环嗜碱性粒细胞浓度显著高于对照组和间质纤维化/肾小管萎缩组。
  • 抗体介导排斥反应组血清MxA水平显著高于对照组,并与IgE沉积程度相关。

临床怎么用

  • 在抗体介导排斥反应评估中可关注移植肾IgE沉积及嗜碱性粒细胞、肥大细胞浸润。
  • 血清MxA或可作为反映IgE沉积程度的潜在标志物,但需进一步验证。

局限性

  • 横断面设计无法确立因果关系。
  • 样本量有限,包括56例抗体介导排斥反应、80例对照、16例间质纤维化/肾小管萎缩和6例SLE。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Active antibody-mediated rejection is the main cause of kidney transplant loss, sharing with SLE the alloimmune response and the systemic activation of the IFN-α pathway. IgE-mediated immune response plays a key role in the development of SLE nephritis and is associated with IFN-α secretion. The aim of our study was to investigate IgE-mediated immune response in antibody-mediated rejection. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a cross-sectional study of 56 biopsy-proven antibody-mediated rejection study participants, 80 recipients with normal graft function/histology (control), 16 study participants with interstitial fibrosis/tubular atrophy, and six participants with SLE. We evaluated graft IgE deposition, tryptase (a mast cell marker), and CD203 (a specific marker of activated basophils) by immunofluorescence/confocal microscopy. In addition, we measured serum concentration of human myxovirus resistance protein 1, an IFN-α-induced protein, and anti-HLA IgE. RESULTS: We observed a significantly higher IgE deposition in tubules and glomeruli in antibody-mediated rejection (1766±79 pixels) and SLE (1495±43 pixels) compared with interstitial fibrosis/tubular atrophy (582±122 pixels) and control (253±50 pixels). Patients with antibody-mediated rejection, but not control patients and patients with interstitial fibrosis/tubular atrophy, presented circulating anti-HLA IgE antibodies, although with a low mean fluorescence intensity. In addition, immunofluorescence revealed the presence of both mast cells and activated basophils in antibody-mediated rejection but not in control and interstitial fibrosis/tubular atrophy. The concentration of circulating basophils was significantly higher in antibody-mediated rejection compared with control and interstitial fibrosis/tubular atrophy. MxA serum levels were significantly higher in antibody-mediated rejection compared with control and correlated with the extent of IgE deposition. CONCLUSIONS: Our data suggest that IgE deposition and the subsequent recruitment of basophils and mast cells within the kidney transplant might play a role in antibody-mediated rejection.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Rascio F, Pontrelli P, Netti GS, et al. IgE-Mediated Immune Response and Antibody-Mediated Rejection. Clin J Am Soc Nephrol. 2020. PMID: 32907809. doi:10.2215/CJN.02870320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。